MORE ABOUT THE DRUG. IN THE BATTLE AGAINST ADDICTION. XYLAZINE ADDS AN EXTRA LAYER TO THE OPIOID CRISIS IN 2023. UNDER THE CONTROLLED SUBSTANCE ACT, THE TRANQUILIZER WAS DECLARED A SCHEDULE THREE DRUG ...
Philadelphia doctors have been on the front lines of the latest ugly chapter of the opioid epidemic – managing xylazine wounds in people who inject drugs. Increasingly across Philadelphia, illicit ...
The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and antianxiety medications in adolescents and young adults has increased sharply since 2001, according to Rutgers Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results